Orthostatic hypotension

Harvard University, Cambridge, Massachusetts, United States
Clinics in Geriatric Medicine (Impact Factor: 3.19). 06/2002; 18(2):253-68. DOI: 10.1016/S0749-0690(02)00008-3
Source: PubMed

ABSTRACT A common problem among elderly people, orthostatic hypotension is associated with significant morbidity and mortality, which may be caused by medications, the cumulative effects of age- and hypertension-related alterations in blood pressure regulation, or age-associated diseases that impair autonomic function. Evaluation requires multiple blood pressure measurements taken at different times of the day and after meals or medications. Central and peripheral nervous system disorders should be sought, and the laboratory evaluation should concentrate on ruling out diabetes mellitus, amyloidosis, occult malignancy, and vitamin deficiencies. If orthostatic hypotension is detected, it should be considered a risk factor for adverse outcomes and treated first with nonpharmacologic interventions, including the withdrawal of potentially hypotensive medications. In patients with hypertension and orthostatic hypotension, the judicious treatment of hypertension may be helpful. For persistent, symptomatic orthostatic hypotension caused by autonomic failure, pharmacologic interventions include fludrocortisone, midodrine, and a variety of other agents. The careful evaluation and management of orthostatic hypotension will hopefully result in a significant reduction in falls, syncope, and fractures, and an attenuation of functional decline in elderly patients.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The syndrome of falls is a common and an often serious problem in elderly people. The cause of falls is multifactorial, and medication use can be a significant contributor. The observational nature of the research in this field makes it difficult to draw conclusions regarding medication use and falls in clinical practice, although psychotropic drugs appear to be most strongly associated with falls. Medication assessment is an important part of evaluating elderly patients at risk for falling.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Orthostatic hypotension (OH) is closely associated with falls, cardiovascular events and mortality in the elderly patients. The aim of the study is to evaluate the OH prevalence among patients over the age of 65 years, to find out the impact of this condition on daily living activities, and to determine the possible effects of vitamin D levels on OH in elderly patients. Eight hundred and forty nine geriatric patients who had undergone comprehensive geriatric assessment were retrospectively evaluated and 546 patients were included in the study. The patient's demographic characteristics, blood pressures, comorbid diseases, polypharmacy status, cognitive and nutritional states, basic and instrumental daily living activity indexes and laboratory values were obtained from hospital files. Serum 25-hydroxyvitamin D [25(OH)D] was measured by radioimmunoassay. The prevalence of OH was found to be 27.5%. Both daily living activity indexes were significantly lower in older patients with OH (p < 0.02), and serum 25(OH)D levels were significantly lower in older patients with OH (p < 0.01). Our findings suggest that Vitamin D deficiency may be a factor in OH development. Because this condition is also preventable and correctable, serum vitamin D levels should be checked during the evaluation of OH patients and any detected deficiency should be treated accordingly.
    Archives of gerontology and geriatrics 09/2014; DOI:10.1016/j.archger.2014.03.008 · 1.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The present study investigated the effects of repeated administration of Korodin®, a combination of camphor and crataegus berry extract, on blood pressure and attentional functioning. This study was conducted based on a randomized, placebo-controlled, double-blind design. 54 persons participated (33 female, 21 male) with a mean age of 24.3 years. Blood pressure and body mass index were in the normal range. Participants received 20 drops of either Korodin® or a placebo for four times with interjacent time intervals of about 10 min. Blood pressure was measured sphygmomanometrically before and after each administration. Attentional performance was quantified by using two paper-and-pencil tests, the d2 Test of Attention and Digit Symbol Test. Greater increases in blood pressure occurred after the four Korodin® administrations in comparison to the four placebo administrations. The performance in two parameters of d2 Test of Attention was consistently superior after the intake of Korodin®. The excellent tolerability and safety of Korodin®, even after a total consumption of 80 drops, was confirmed.
    Phytomedicine 09/2014; 21(11):1349–1355. DOI:10.1016/j.phymed.2014.06.014 · 2.88 Impact Factor